These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2472397)

  • 1. Mapping of a putative surface-binding site of human coagulation factor XII.
    Clarke BJ; Côté HC; Cool DE; Clark-Lewis I; Saito H; Pixley RA; Colman RW; MacGillivray RT
    J Biol Chem; 1989 Jul; 264(19):11497-502. PubMed ID: 2472397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Stumpo LG; Birkmeyer K; Silver L; Colman RW
    J Biol Chem; 1987 Jul; 262(21):10140-5. PubMed ID: 2440859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
    J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody recognizing an iscosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Colman RW
    Adv Exp Med Biol; 1989; 247A():473-6. PubMed ID: 2481390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
    Piétu G; Ribba AS; Chérel G; Meyer D
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
    Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
    Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
    Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S; Gaucher C; Piétu G; Chérel G; Meyer D; Mazurier C
    Br J Haematol; 1994 May; 87(1):113-8. PubMed ID: 7524613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses.
    Inomo A; Sugi T; Fujita Y; Matsubayashi H; Izumi S; Mikami M
    Thromb Haemost; 2008 Feb; 99(2):316-23. PubMed ID: 18278180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
    Small EJ; Katzmann JA; Tracy RP; Ratnoff OD; Goldsmith GH; Everson B
    Blood; 1985 Jan; 65(1):202-10. PubMed ID: 3965048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of monoclonal antibodies to keratin 19 using keratin fragments, synthetic peptides and phage peptide libraries.
    Böttger V; Stasiak PC; Harrison DL; Mellerick DM; Lane EB
    Eur J Biochem; 1995 Jul; 231(2):475-85. PubMed ID: 7543411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive epitope analysis of monoclonal anti-proenkephalin antibodies using phage display libraries and synthetic peptides: revelation of antibody fine specificities caused by somatic mutations in the variable region genes.
    Böttger V; Böttger A; Lane EB; Spruce BA
    J Mol Biol; 1995 Apr; 247(5):932-46. PubMed ID: 7536850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa.
    Cool DE; Edgell CJ; Louie GV; Zoller MJ; Brayer GD; MacGillivray RT
    J Biol Chem; 1985 Nov; 260(25):13666-76. PubMed ID: 3877053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
    Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.
    Ginsburg D; Bockenstedt PL; Allen EA; Fox DA; Foster PA; Ruggeri ZM; Zimmerman TS; Montgomery RR; Bahou WF; Johnson TA
    Thromb Haemost; 1992 Jan; 67(1):166-71. PubMed ID: 1377414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.